X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 60 filers reported holding X4 PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 2.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,082 | -43.8% | 30,350 | 0.0% | 0.00% | – |
| Q2 2023 | $58,879 | +123.0% | 30,350 | 0.0% | 0.00% | – |
| Q1 2023 | $26,405 | -14.4% | 30,350 | -2.3% | 0.00% | – |
| Q4 2022 | $30,840 | -41.8% | 31,057 | 0.0% | 0.00% | – |
| Q3 2022 | $53,000 | +165.0% | 31,057 | +47.5% | 0.00% | – |
| Q2 2022 | $20,000 | +5.3% | 21,057 | +90.4% | 0.00% | – |
| Q1 2022 | $19,000 | -20.8% | 11,057 | +6.8% | 0.00% | – |
| Q4 2021 | $24,000 | -56.4% | 10,350 | 0.0% | 0.00% | – |
| Q3 2021 | $55,000 | -17.9% | 10,350 | 0.0% | 0.00% | – |
| Q2 2021 | $67,000 | -24.7% | 10,350 | 0.0% | 0.00% | – |
| Q1 2021 | $89,000 | +32.8% | 10,350 | 0.0% | 0.00% | – |
| Q4 2020 | $67,000 | -4.3% | 10,350 | 0.0% | 0.00% | – |
| Q3 2020 | $70,000 | -27.1% | 10,350 | 0.0% | 0.00% | – |
| Q2 2020 | $96,000 | -7.7% | 10,350 | 0.0% | 0.00% | – |
| Q1 2020 | $104,000 | -6.3% | 10,350 | 0.0% | 0.00% | – |
| Q4 2019 | $111,000 | 0.0% | 10,350 | +19.0% | 0.00% | – |
| Q3 2019 | $111,000 | -4.3% | 8,700 | +13.0% | 0.00% | – |
| Q2 2019 | $116,000 | – | 7,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 311,492 | $2,682,000 | 3.48% |
| Sio Capital Management, LLC | 804,597 | $6,928,000 | 1.41% |
| Bain Capital Life Sciences Investors, LLC | 2,119,540 | $18,249,000 | 1.03% |
| SV Health Investors, LLC | 311,490 | $2,682,000 | 1.00% |
| Monashee Investment Management LLC | 574,712 | $4,948,000 | 0.76% |
| Ikarian Capital, LLC | 2,614,988 | $22,515,000 | 0.76% |
| Abingworth LLP | 229,885 | $1,956,000 | 0.68% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $2,884,000 | 0.67% |
| BVF INC/IL | 1,091,579 | $9,398,000 | 0.35% |
| Endurant Capital Management LP | 151,996 | $1,309,000 | 0.34% |